IT1393419B1 - Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. - Google Patents
Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6.Info
- Publication number
- IT1393419B1 IT1393419B1 ITRM2009A000119A ITRM20090119A IT1393419B1 IT 1393419 B1 IT1393419 B1 IT 1393419B1 IT RM2009A000119 A ITRM2009A000119 A IT RM2009A000119A IT RM20090119 A ITRM20090119 A IT RM20090119A IT 1393419 B1 IT1393419 B1 IT 1393419B1
- Authority
- IT
- Italy
- Prior art keywords
- omega
- fatty acids
- ophthalmic compositions
- polysaturated fatty
- polysaturated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
- A01N43/04—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom
- A01N43/14—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings
- A01N43/16—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with one hetero atom six-membered rings with oxygen as the ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Priority Applications (18)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2009A000119A IT1393419B1 (it) | 2009-03-19 | 2009-03-19 | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
US13/256,994 US8957110B2 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
SI201031418A SI2408426T1 (sl) | 2009-03-19 | 2010-03-18 | Oftalmični sestavki na osnovi polinenasičenih omega-3 in omega-6 maščobnih kislin |
ES10717302.3T ES2617683T3 (es) | 2009-03-19 | 2010-03-18 | Composiciones oftálmicas basadas en ácidos grasos Omega-3 y Omega-6 poliinsaturados |
CA2754568A CA2754568C (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
RS20170253A RS55859B1 (sr) | 2009-03-19 | 2010-03-18 | Oftamološke kompozicije zasnovane na polinezasićenim omega-3 i omega-6 masnim kiselinama |
RU2011142146/15A RU2545675C2 (ru) | 2009-03-19 | 2010-03-18 | Офтальмическая композиция на основе полиненасыщенных жирных кислот омега-3 и омега-6 |
MX2011009740A MX2011009740A (es) | 2009-03-19 | 2010-03-18 | Coposiciones oftalmicas basadas en acidos grasos omega-3 y omega-6. |
EP10717302.3A EP2408426B1 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
PT107173023T PT2408426T (pt) | 2009-03-19 | 2010-03-18 | Composições oftálmicas baseadas em ácidos gordos poliinsaturados ómega 3 e ómega 6 |
BRPI1009281A BRPI1009281A2 (pt) | 2009-03-19 | 2010-03-18 | composição oftálmica tópica |
PL10717302T PL2408426T3 (pl) | 2009-03-19 | 2010-03-18 | Kompozycje dooczne na bazie wielonienasyconych kwasów tłuszczowych omega-3 i omega-6 |
PCT/IT2010/000119 WO2010106571A2 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
CN201080012341.0A CN102355889B (zh) | 2009-03-19 | 2010-03-18 | 基于多不饱和ω-3和ω-6脂肪酸的眼用组合物 |
HUE10717302A HUE031869T2 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic preparations based on polyunsaturated omega-3 and omega-6 fatty acids |
DK10717302.3T DK2408426T3 (en) | 2009-03-19 | 2010-03-18 | Ophthalmic composition based on polyunsaturated omega-3 and omega-6 fatty acids |
KR1020117021744A KR101677308B1 (ko) | 2009-03-19 | 2010-03-18 | 오메가-3 및 오메가-6 다가 불포화 지방산계 안과용 조성물 |
HK12107538.0A HK1166714A1 (en) | 2009-03-19 | 2012-08-01 | Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids -3 -6 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITRM2009A000119A IT1393419B1 (it) | 2009-03-19 | 2009-03-19 | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
Publications (2)
Publication Number | Publication Date |
---|---|
ITRM20090119A1 ITRM20090119A1 (it) | 2010-09-19 |
IT1393419B1 true IT1393419B1 (it) | 2012-04-20 |
Family
ID=41213320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITRM2009A000119A IT1393419B1 (it) | 2009-03-19 | 2009-03-19 | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. |
Country Status (18)
Country | Link |
---|---|
US (1) | US8957110B2 (it) |
EP (1) | EP2408426B1 (it) |
KR (1) | KR101677308B1 (it) |
CN (1) | CN102355889B (it) |
BR (1) | BRPI1009281A2 (it) |
CA (1) | CA2754568C (it) |
DK (1) | DK2408426T3 (it) |
ES (1) | ES2617683T3 (it) |
HK (1) | HK1166714A1 (it) |
HU (1) | HUE031869T2 (it) |
IT (1) | IT1393419B1 (it) |
MX (1) | MX2011009740A (it) |
PL (1) | PL2408426T3 (it) |
PT (1) | PT2408426T (it) |
RS (1) | RS55859B1 (it) |
RU (1) | RU2545675C2 (it) |
SI (1) | SI2408426T1 (it) |
WO (1) | WO2010106571A2 (it) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ596932A (en) | 2009-06-05 | 2014-04-30 | Allergan Inc | Artificial tears and therapeutic uses |
US20130295171A1 (en) | 2009-07-23 | 2013-11-07 | U.S NUTRACEUTICALS, LLC d/b/a Valensa International | Krill oil and reacted astaxanthin composition and associated method |
US20130011469A1 (en) | 2009-07-23 | 2013-01-10 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Krill oil and carotenoid composition, associated method and delivery system |
US20110237548A1 (en) * | 2009-07-23 | 2011-09-29 | U.S. Nutraceuticals, Llc D/B/A Valensa International | Synergistic composition and method of retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
WO2011051743A1 (en) | 2009-10-30 | 2011-05-05 | Tharos Ltd. | Solvent-free process for obtaining phospholipids and neutral enriched krill oils |
EP2547323B1 (en) | 2010-03-17 | 2016-01-27 | Novaliq GmbH | Pharmaceutical composition for treatment of increased intraocular pressure |
EP2444063A1 (en) | 2010-10-20 | 2012-04-25 | Novaliq GmbH | Liquid pharmaceutical compositions for the delivery of active ingredients |
EP2462921A1 (en) | 2010-11-11 | 2012-06-13 | Novaliq GmbH | Liquid pharmaceutical compositions for the treatment of a posterior eye disease |
EP2714008B1 (en) | 2011-05-25 | 2016-12-14 | Novaliq GmbH | Pharmaceutical composition for administration to nails |
US10130707B2 (en) | 2011-05-25 | 2018-11-20 | Novaliq Gmbh | Topical pharmaceutical composition based on semifluorinated alkanes |
US10383839B2 (en) * | 2011-06-30 | 2019-08-20 | Johnson & Johnson Vision Care, Inc. | Esters for treatment of ocular inflammatory conditions |
US9381183B2 (en) * | 2012-07-18 | 2016-07-05 | Physicians Recommended Nutriceuticals, Llc | Methods for improving the quality of the meibum composition of meibomian glands |
CA2845868C (en) * | 2011-09-12 | 2018-11-06 | Tassos GEORGIOU | Use of epa and dha in treating occular disorder |
HUE042760T2 (hu) | 2011-12-23 | 2019-07-29 | Western Sydney Univ | Szemészeti készítmény |
PT2806886T (pt) | 2012-01-23 | 2017-03-24 | Novaliq Gmbh | Composições de proteínas estabilizadas baseadas em alcanos semifluorados |
WO2014035450A1 (en) * | 2012-08-31 | 2014-03-06 | Bausch & Lomb Incorporated | Ophthalmic compositions with omega-3 fatty acids |
CA2883002C (en) | 2012-09-12 | 2019-05-21 | Novaliq Gmbh | Compositions comprising mixtures of semifluorinated alkanes |
EP4342537A2 (en) | 2012-09-12 | 2024-03-27 | Novaliq GmbH | Semifluorinated alkane compositions |
ES2687094T3 (es) | 2013-07-23 | 2018-10-23 | Novaliq Gmbh | Composiciones estabilizadas de anticuerpos |
WO2015138224A1 (en) * | 2014-03-13 | 2015-09-17 | Sears Barry D | Compositions and methods for reducing chronic low-level inflammation |
NZ732058A (en) | 2014-11-25 | 2023-06-30 | Allergan Inc | Stabilized omega-3 ophthalmic compositions |
WO2016162894A1 (en) * | 2015-04-08 | 2016-10-13 | For Health Pharma S.R.L. | Ophthalmic compositions based on polyunsaturated fatty acids and triacylglycerols |
US10966937B2 (en) * | 2015-05-04 | 2021-04-06 | Cytometix, Inc. | Compositions and methods for delivery of polyunsaturated fatty acid derivatives and analogs |
JP6602964B2 (ja) | 2015-09-30 | 2019-11-06 | ノバリック ゲーエムベーハー | 半フッ素化化合物およびその組成物 |
EP4234523A1 (en) | 2015-09-30 | 2023-08-30 | Novaliq GmbH | Semifluorinated compounds for ophthalmic administration |
NZ747413A (en) | 2016-04-27 | 2020-09-25 | Anika Therapeutics Inc | Compositions for use in treating tendon degeneration |
PL3442480T3 (pl) | 2016-06-23 | 2020-04-30 | Novaliq Gmbh | Sposób podawania miejscowego |
ES2650981B2 (es) | 2016-07-20 | 2018-05-04 | Ocupharm Diagnostics, Sl | Preparación y uso de un extracto de Artemia salina para tratar la superficie ocular |
KR20190055153A (ko) | 2016-09-21 | 2019-05-22 | 아벡신 에이에스 | 약학 조성물 |
AU2017329772B2 (en) | 2016-09-22 | 2023-02-02 | Novaliq Gmbh | Pharmaceutical compositions for use in the therapy of blepharitis |
JP6869336B2 (ja) | 2016-09-23 | 2021-05-12 | ノバリック ゲーエムベーハー | シクロスポリンを含む眼科用組成物 |
US10786441B2 (en) | 2016-11-21 | 2020-09-29 | Skinintegra, Inc. | Skin barrier repair and maintenance composition |
AU2018253944B2 (en) | 2017-04-21 | 2022-09-15 | Dermaliq Therapeutics, Inc. | Iodine compositions |
EP3621601A1 (en) | 2017-05-12 | 2020-03-18 | Novaliq GmbH | Pharmaceutical compositions comprosing semifluorinated alkanes for the treatment of contact lense-related conditions |
KR20200059272A (ko) | 2017-09-27 | 2020-05-28 | 노바리크 게엠베하 | 안구 질환의 치료에서의 사용을 위한 라타노프로스트를 포함하는 안과적 조성물 |
WO2019068763A1 (en) | 2017-10-04 | 2019-04-11 | Novaliq Gmbh | OPHTHALMIC COMPOSITIONS COMPRISING F6H8 |
WO2019166631A1 (en) | 2018-03-02 | 2019-09-06 | Novaliq Gmbh | Pharmaceutical compositions comprising nebivolol |
KR20210003877A (ko) * | 2018-05-01 | 2021-01-12 | 치비 인코포레이티드 | 약제를 눈에 비침습적으로 지속 전달하기 위한 액체 데포 |
WO2019213326A1 (en) | 2018-05-01 | 2019-11-07 | Idrop, Inc. | Eye drop formulation and method for sustained delivery of medicament to the retina |
NO345574B1 (en) * | 2018-06-19 | 2021-04-26 | Epax Norway As | Composition for treatment of dry eye disease and meibomianitis |
AU2019358249B2 (en) | 2018-10-12 | 2024-02-22 | Novaliq Gmbh | Ophthalmic composition for treatment of dry eye disease |
WO2020083760A1 (en) * | 2018-10-22 | 2020-04-30 | Dsm Ip Assets B.V. | Composition exhibiting enhanced oxidative stability |
KR102275250B1 (ko) * | 2018-12-21 | 2021-07-08 | 윤영선 | 셀레늄과 프로폴리스를 유효성분으로 포함하는 안구 건조증 예방 및 치료용 조성물 |
WO2021194360A1 (en) * | 2020-03-27 | 2021-09-30 | Pharmazen Limited | Extraction method for bio-active fractions |
CN114073670B (zh) * | 2020-08-11 | 2023-02-24 | 武汉科福新药有限责任公司 | 马来酸噻吗洛尔凝胶滴眼液及其制备方法 |
MX2021003369A (es) * | 2021-03-22 | 2022-09-23 | Laboratorios Grin S A De C V | Lágrima ocular triple. |
US11951123B2 (en) | 2022-01-12 | 2024-04-09 | Platform Ophthalmic Innovations, LLC | Fortified nutritional lubricating drops for dry eye disease |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2013755C (en) | 1989-04-05 | 1993-11-30 | Simon Benita | Medicinal emulsions |
JP2873530B2 (ja) * | 1991-12-13 | 1999-03-24 | 参天製薬株式会社 | ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤 |
US6201022B1 (en) * | 1997-03-27 | 2001-03-13 | Myorx, Inc. | Methods for treating neurotransmitter-mediated pain syndromes by topically administering an omega fatty acid |
IT1304406B1 (it) * | 1998-10-21 | 2001-03-19 | Danital Italia S R L | Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3. |
PT102509A (pt) * | 2000-08-16 | 2002-02-28 | Fundacao Essprit Icarus | Composicoes farmaceuticas, cosmeticas e dermo-cosmeticas, de higiene, alimentares e para-alimentares a base de oleo de foca, e sua utilizacao |
US20040076695A1 (en) * | 2002-07-08 | 2004-04-22 | Advanced Vision Research | EPA and DHA enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
US20040208939A1 (en) * | 2003-04-18 | 2004-10-21 | Barry Sears | Novel dietary compositions to reduce inflammation |
US7390507B2 (en) * | 2004-04-13 | 2008-06-24 | Ruwart Mary J | Compositions and methods for the treatment of radiation burns and other traumatic skin conditions |
CA2572344A1 (en) * | 2004-07-01 | 2006-01-19 | Schepens Eye Research | Compositions and methods for treating eye disorders and conditions |
EP1968402A2 (en) * | 2005-10-07 | 2008-09-17 | Ocean Nutrition Canada Limited | Salts of fatty acids and methods of making and using thereof |
US20070207116A1 (en) * | 2006-03-01 | 2007-09-06 | Brown David C | Antioxidant compositions for the eye |
BRPI0709549A2 (pt) * | 2006-03-17 | 2011-07-19 | Johnson & Johnson Vision Care | métodos para estabilizar composições instáveis oxidativamente |
-
2009
- 2009-03-19 IT ITRM2009A000119A patent/IT1393419B1/it active
-
2010
- 2010-03-18 SI SI201031418A patent/SI2408426T1/sl unknown
- 2010-03-18 BR BRPI1009281A patent/BRPI1009281A2/pt not_active Application Discontinuation
- 2010-03-18 MX MX2011009740A patent/MX2011009740A/es active IP Right Grant
- 2010-03-18 WO PCT/IT2010/000119 patent/WO2010106571A2/en active Application Filing
- 2010-03-18 CN CN201080012341.0A patent/CN102355889B/zh active Active
- 2010-03-18 RU RU2011142146/15A patent/RU2545675C2/ru active
- 2010-03-18 EP EP10717302.3A patent/EP2408426B1/en active Active
- 2010-03-18 CA CA2754568A patent/CA2754568C/en active Active
- 2010-03-18 PL PL10717302T patent/PL2408426T3/pl unknown
- 2010-03-18 US US13/256,994 patent/US8957110B2/en active Active
- 2010-03-18 ES ES10717302.3T patent/ES2617683T3/es active Active
- 2010-03-18 KR KR1020117021744A patent/KR101677308B1/ko active IP Right Grant
- 2010-03-18 RS RS20170253A patent/RS55859B1/sr unknown
- 2010-03-18 HU HUE10717302A patent/HUE031869T2/en unknown
- 2010-03-18 PT PT107173023T patent/PT2408426T/pt unknown
- 2010-03-18 DK DK10717302.3T patent/DK2408426T3/en active
-
2012
- 2012-08-01 HK HK12107538.0A patent/HK1166714A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DK2408426T3 (en) | 2017-03-27 |
CN102355889A (zh) | 2012-02-15 |
SI2408426T1 (sl) | 2017-04-26 |
PT2408426T (pt) | 2017-03-06 |
PL2408426T3 (pl) | 2017-07-31 |
EP2408426B1 (en) | 2016-12-14 |
US20120010280A1 (en) | 2012-01-12 |
KR20110130431A (ko) | 2011-12-05 |
ES2617683T3 (es) | 2017-06-19 |
EP2408426A2 (en) | 2012-01-25 |
CA2754568C (en) | 2017-07-18 |
RS55859B1 (sr) | 2017-08-31 |
WO2010106571A2 (en) | 2010-09-23 |
WO2010106571A3 (en) | 2010-11-18 |
CN102355889B (zh) | 2015-01-28 |
HUE031869T2 (en) | 2017-08-28 |
ITRM20090119A1 (it) | 2010-09-19 |
KR101677308B1 (ko) | 2016-11-17 |
RU2545675C2 (ru) | 2015-04-10 |
US8957110B2 (en) | 2015-02-17 |
MX2011009740A (es) | 2011-09-29 |
HK1166714A1 (en) | 2012-11-09 |
RU2011142146A (ru) | 2013-04-27 |
BRPI1009281A2 (pt) | 2016-03-08 |
CA2754568A1 (en) | 2010-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IT1393419B1 (it) | Composizioni oftalmiche a base di acidi grassi polinsaturi omega-3 e omega-6. | |
IL249821A0 (en) | Preparations of omega 3 fatty acid esters | |
EP2846779A4 (en) | STATIN AND OMEGA-3 FATTY ACID COMPOSITIONS | |
DK3159329T3 (da) | Anvendelse af 2-hidroxyderivater af polyumættede fedtsyrer som medikamenter | |
DK2575787T3 (da) | Farmaceutiske formuleringer af statiner og omega-3-fedtsyrer til indkapsling | |
CO6801786A2 (es) | Ésteres grasos alcoxilados de la metátesis de aceites naturales y sus derivados | |
DK2429317T4 (da) | Sammensætninger med højt indhold af omega-3-fedtsyrer og med lavt indhold af phytansyre | |
IL228516A (en) | A compound for oral administration containing an omega-3 fatty acid ester and rosovastatin | |
DK2424520T3 (da) | Anvendelse af flerumættede fedtsyrer til behandling af hudinflammation | |
ZA201202263B (en) | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same | |
ZA201403784B (en) | Compositions comprising 20-carbon fatty acids and methods of making and using same | |
CO6950485A2 (es) | Composiciones perfumantes y usos de las mismas | |
DK1996536T3 (da) | Fremgangsmåde til decarboxylering af fedtsyrer | |
DK2164520T3 (da) | Cyclodextriner til indgivelse af fedtsyrer i tabletter | |
ZA201302760B (en) | Novel omega-3 and omega-6 fatty acid compositions and uses thereof | |
PL2774910T3 (pl) | Enancjomery 2-hydroksy pochodnych kwasów tłuszczowych | |
CO6990703A2 (es) | Desacificación de grasas y aceites | |
HUE038592T2 (hu) | Telítetlen zsírsavak és ezek származékai ózonizálása | |
CL2016001278A1 (es) | Producción de ácidos grasos poliinsaturados de cadena larga omega 3 en los cultivos de oleaginosas por una sintasa pufa traustoquitridio | |
EP2706847A4 (en) | COUPLERS FOR MEDIUM CHAIN FATTY ACIDS AND DISINFECTANT COMPOSITIONS | |
EP2931065A4 (en) | PROCESS FOR PREPARING AND COMPOSITIONS WITH VEGETABLE OMEGA-3 FATTY ACIDS | |
ITMI20072142A1 (it) | Composizioni farmaceutiche contenenti statine e derivati di acidi grassi omega-3 | |
HK1200712A1 (en) | Stable formulations of antiplatelet agents, omega-3 fatty acids and amylose in soft gelatin capsules -3 | |
ITUA20163758A1 (it) | Ossidi misti polifunzionali per la scissione ossidativa di lipidi e di metil esteri di acidi grassi insaturi | |
BRPI0816733A2 (pt) | produção de ácido graxo e éster de ácido graxo |